[
  {
    "ts": "2026-01-30T07:07:17+00:00",
    "headline": "EPKINLY Trial Results Prompt Price Target Cut for Genmab (GMAB)",
    "summary": "Genmab A/S (NASDAQ:GMAB) ranks among the best high growth European stocks to buy. On January 20, H.C. Wainwright cut its price target for Genmab A/S (NASDAQ:GMAB) to $39 from $41, retaining a Buy rating on the company’s shares. The change comes after Genmab and partner AbbVie announced that their Phase 3 EPCORE DLBCL-1 trial found […]",
    "url": "https://finance.yahoo.com/news/epkinly-trial-results-prompt-price-070717523.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "dcc30dec-20dc-3cb2-a486-98d6c9ff3ed1",
      "content": {
        "id": "dcc30dec-20dc-3cb2-a486-98d6c9ff3ed1",
        "contentType": "STORY",
        "title": "EPKINLY Trial Results Prompt Price Target Cut for Genmab (GMAB)",
        "description": "",
        "summary": "Genmab A/S (NASDAQ:GMAB) ranks among the best high growth European stocks to buy. On January 20, H.C. Wainwright cut its price target for Genmab A/S (NASDAQ:GMAB) to $39 from $41, retaining a Buy rating on the company’s shares. The change comes after Genmab and partner AbbVie announced that their Phase 3 EPCORE DLBCL-1 trial found […]",
        "pubDate": "2026-01-30T07:07:17Z",
        "displayTime": "2026-01-30T07:07:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/02fcbbad2abad8b764e699aa3a675314",
          "originalWidth": 640,
          "originalHeight": 427,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dNNfiqZU0wSeWAqQUW_1yg--~B/aD00Mjc7dz02NDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/02fcbbad2abad8b764e699aa3a675314.cf.webp",
              "width": 640,
              "height": 427,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xk2.Is4xMYeWQc.GTH.r4A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/02fcbbad2abad8b764e699aa3a675314.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/epkinly-trial-results-prompt-price-070717523.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/epkinly-trial-results-prompt-price-070717523.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GMAB"
            },
            {
              "symbol": "GNMSF"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "RHHBF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-30T14:15:10+00:00",
    "headline": "Stay Ahead of the Game With AbbVie (ABBV) Q4 Earnings: Wall Street's Insights on Key Metrics",
    "summary": "Get a deeper insight into the potential performance of AbbVie (ABBV) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.",
    "url": "https://finance.yahoo.com/news/stay-ahead-game-abbvie-abbv-141510153.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "4a67402f-c2cc-3ff5-bbc9-c9b102371f70",
      "content": {
        "id": "4a67402f-c2cc-3ff5-bbc9-c9b102371f70",
        "contentType": "STORY",
        "title": "Stay Ahead of the Game With AbbVie (ABBV) Q4 Earnings: Wall Street's Insights on Key Metrics",
        "description": "",
        "summary": "Get a deeper insight into the potential performance of AbbVie (ABBV) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.",
        "pubDate": "2026-01-30T14:15:10Z",
        "displayTime": "2026-01-30T14:15:10Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a",
          "originalWidth": 900,
          "originalHeight": 728,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qda7CGFBlQ8XGALeSrKgqg--~B/aD03Mjg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a.cf.webp",
              "width": 900,
              "height": 728,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4xjRGdTikgXo5SMeFUiNTA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/stay-ahead-game-abbvie-abbv-141510153.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/stay-ahead-game-abbvie-abbv-141510153.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-30T13:53:26+00:00",
    "headline": "AbbVie Stock: Analyst Estimates & Ratings",
    "summary": "After Humira’s patent cliff, what do analysts think about AbbVie’s stock now?",
    "url": "https://www.barchart.com/story/news/37321684/abbvie-stock-analyst-estimates-ratings",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "473dbc43-82a0-390b-b75d-749160ffcebe",
      "content": {
        "id": "473dbc43-82a0-390b-b75d-749160ffcebe",
        "contentType": "STORY",
        "title": "AbbVie Stock: Analyst Estimates & Ratings",
        "description": "",
        "summary": "After Humira’s patent cliff, what do analysts think about AbbVie’s stock now?",
        "pubDate": "2026-01-30T13:53:26Z",
        "displayTime": "2026-01-30T13:53:26Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/2bb8d4b77463809e4fc570db18f84b10",
          "originalWidth": 1000,
          "originalHeight": 750,
          "caption": "Abbvie Inc logo and stock chart-by IgorGolovniov via Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9YBNPTVlnFlcnAr7S8ulsg--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/barchart_com_477/2bb8d4b77463809e4fc570db18f84b10.cf.webp",
              "width": 1000,
              "height": 750,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Buy.NCFRKiCSEIoFMEGUIA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/2bb8d4b77463809e4fc570db18f84b10.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/37321684/abbvie-stock-analyst-estimates-ratings",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-stock-analyst-estimates-ratings-135326468.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-30T20:50:00+00:00",
    "headline": "Better Long-Term Buy: This Emerging Player or the Industry Leader?",
    "summary": "The choice between the two might come down to each investor's goals and risk tolerance.",
    "url": "https://www.fool.com/investing/2026/01/30/better-long-term-buy-this-emerging-player-or-the-i/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "686cdf2c-d258-3b0f-98a6-cdcf4d92624f",
      "content": {
        "id": "686cdf2c-d258-3b0f-98a6-cdcf4d92624f",
        "contentType": "STORY",
        "title": "Better Long-Term Buy: This Emerging Player or the Industry Leader?",
        "description": "",
        "summary": "The choice between the two might come down to each investor's goals and risk tolerance.",
        "pubDate": "2026-01-30T20:50:00Z",
        "displayTime": "2026-01-30T20:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/a0dd5f172eacb35cb35b2da7a3564211",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Patient taking medicine.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_6mCuG7L4R1J2BWXRpIqfw--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/a0dd5f172eacb35cb35b2da7a3564211.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/c5RQew1OvxJ48uFw3A_jmA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/a0dd5f172eacb35cb35b2da7a3564211.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/01/30/better-long-term-buy-this-emerging-player-or-the-i/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/better-long-term-buy-emerging-205000832.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "ABVX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]